210 related articles for article (PubMed ID: 37761936)
1. The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.
Pitea M; Canale FA; Porto G; Verduci C; Utano G; Policastro G; Alati C; Santoro L; Imbalzano L; Martino M
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761936
[TBL] [Abstract][Full Text] [Related]
2. Noncoding RNAs in diagnosis and prognosis of graft-versus-host disease (GVHD).
Vajari MK; Moradinasab S; Yousefi AM; Bashash D
J Cell Physiol; 2022 Sep; 237(9):3480-3495. PubMed ID: 35842836
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
4. Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
Weiner DM; Lewis DJ; Spaccarelli NG; Clark RA; Nasta SD; Loren AW; Rook AH; Kim EJ
Dermatol Ther; 2022 Jul; 35(7):e15538. PubMed ID: 35477952
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
[TBL] [Abstract][Full Text] [Related]
6. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
[TBL] [Abstract][Full Text] [Related]
7. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease.
Koenecke C; Krueger A
Front Immunol; 2018; 9():992. PubMed ID: 29867969
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
Front Immunol; 2021; 12():785774. PubMed ID: 34987512
[TBL] [Abstract][Full Text] [Related]
12. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
[TBL] [Abstract][Full Text] [Related]
13. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
[TBL] [Abstract][Full Text] [Related]
14. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
15. Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
Maloney DG
Leuk Lymphoma; 2003; 44 Suppl 3():S99-105. PubMed ID: 15202532
[TBL] [Abstract][Full Text] [Related]
16. Oral submucous fibrosis induced by graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Liu B; Cai J; Li W; Liu G; Chen J
Oral Oncol; 2022 Jul; 130():105919. PubMed ID: 35594775
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bu X; Zhong J; Li W; Cai S; Gao Y; Ping B
Ann Hematol; 2021 Jun; 100(6):1391-1400. PubMed ID: 33709198
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.
Tomuleasa C; Fuji S; Cucuianu A; Kapp M; Pileczki V; Petrushev B; Selicean S; Tanase A; Dima D; Berindan-Neagoe I; Irimie A; Einsele H
Ann Hematol; 2015 Jul; 94(7):1081-92. PubMed ID: 25900787
[TBL] [Abstract][Full Text] [Related]
19. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
